Danaher | DHR - Nettoeinkommen

Aktienkurs
177.25
Täglich Wechseln
-1.32 -0.74%
Monatlich
-5.29%
Jährlich
-10.09%
Q2 Prognose
173.46




Nettoeinkommen Veränderung Datum
Abbott USD 1.08B 699M 2026-03
Agilent USD 305M 129M 2025-12
Align Technology USD 135.76M 79.01M 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Bio Techne USD 38.01M 176K 2025-12
Bio-Rad Laboratories USD -341.9M 659.7M 2025-09
Boston Scientific USD 672M 83M 2025-12
Bruker USD 26M 88.4M 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Danaher USD 1.03B 168M 2026-03
Dentsply International USD -146M 281M 2025-12
Edwards Lifesciences USD 380.7M 289.5M 2026-03
ESCO Technologies USD 28.69M 189.96M 2025-12
Fortive USD 185.7M 130.7M 2025-12
Henry Schein USD 101M 0 2025-12
Illumina USD 334M 184M 2025-12
Intuitive Surgical USD 821.5M 26.7M 2026-03
IQVIA Holdings USD 514M 183M 2025-12
Keysight Technologies USD 281M 52M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Medtronic USD 1.14B 231M 2025-12
Mettler Toledo International USD 285.76M 68.27M 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Quest Diagnostics USD 251M 6M 2026-03
Quidel USD -733M 477.6M 2025-09
Repligen USD 13.29M 1.62M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Roper Industries USD 508.9M 80.5M 2026-03
Stryker USD 849M 10M 2025-12
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Waters USD 225.21M 76.29M 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12